CareRx Corp

CareRx Corp maintains a debt-to-equity ratio of 0.71, indicating a moderate reliance on debt financing, while its current ratio of 1.06 suggests limited short-term liquidity cushion. The company's liquidity position is assessed as medium risk, with free cash flow of 34.9 million CAD and operating cash flow of 30.8 million CAD, but net cash is negative after subtracting total debt. This implies that the company may need to manage its debt obligations carefully to maintain financial flexibility. Profitability metrics show a return on equity of 23.86% and a return on assets of 10.75%, both of which are strong indicators of efficient capital use and asset management. These figures suggest that CareRx Corp is generating solid returns relative to its equity and asset base, which is a positive sign for investors. The company's operating income of 10.1 million CAD and net income of 26.1 million CAD further support its profitability. Geographically and segment-wise, the company's revenue concentration is not disclosed in the available data, but its primary business activity is drug retailing, which is likely to be concentrated in its domestic market. The lack of segment-specific revenue data limits the ability to assess geographic or product diversification. The company's growth trajectory is not explicitly outlined in the available data, but its current financial performance suggests a stable and profitable operation. Analysts have provided a mean price target of 5.38 CAD, with a median of 5.38 CAD, and all six recommendations are categorized as "buy". This indicates a generally positive outlook from the investment community, though no specific growth projections are provided in the input data. Risk factors include a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could pose a challenge in maintaining liquidity under stress scenarios. However, the dilution risk is assessed as low, and no adjustments to valuation have been applied, suggesting that the company is not currently facing significant equity issuance pressures. Recent events and filings are not detailed in the input data, but the company's financial performance and analyst recommendations suggest a stable and well-managed business. The absence of recent events or transcripts does not detract from the overall positive assessment of the company's current financial health.